TOLAZAMIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Tolazamide, and when can generic versions of Tolazamide launch?
Tolazamide is a drug marketed by Barr, Chartwell Rx, Cosette, Duramed Pharms Barr, Interpharm, Natco, Par Pharm, Sun Pharm Industries, Superpharm, Usl Pharma, and Watson Labs. and is included in thirty NDAs.
The generic ingredient in TOLAZAMIDE is tolazamide. There are six drug master file entries for this compound. Additional details are available on the tolazamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOLAZAMIDE?
- What are the global sales for TOLAZAMIDE?
- What is Average Wholesale Price for TOLAZAMIDE?
Summary for TOLAZAMIDE
US Patents: | 0 |
Applicants: | 11 |
NDAs: | 30 |
Raw Ingredient (Bulk) Api Vendors: | 73 |
Clinical Trials: | 3 |
Patent Applications: | 4,862 |
DailyMed Link: | TOLAZAMIDE at DailyMed |
Recent Clinical Trials for TOLAZAMIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Drug Safety and Effectiveness Network, Canada | |
Canadian Institutes of Health Research (CIHR) | |
Canadian Network for Observational Drug Effect Studies, CNODES |
Medical Subject Heading (MeSH) Categories for TOLAZAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for TOLAZAMIDE
US Patents and Regulatory Information for TOLAZAMIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Watson Labs | TOLAZAMIDE | tolazamide | TABLET;ORAL | 070244-001 | Aug 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | TOLAZAMIDE | tolazamide | TABLET;ORAL | 070242-001 | Aug 1, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | TOLAZAMIDE | tolazamide | TABLET;ORAL | 070515-001 | Jan 9, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |